135 related articles for article (PubMed ID: 15552798)
1. Signal transduction pathways as novel therapy targets in lung cancer.
Reinmuth N; Mesters RM; Bieker R; Hoffknecht P; Berdel WE; Thomas M
Lung Cancer; 2004 Aug; 45 Suppl 2():S177-86. PubMed ID: 15552798
[TBL] [Abstract][Full Text] [Related]
2. The role of polypeptide growth factors in human carcinomas: new targets for a novel pharmacological approach.
Favoni RE; de Cupis A
Pharmacol Rev; 2000 Jun; 52(2):179-206. PubMed ID: 10835099
[TBL] [Abstract][Full Text] [Related]
3. Targeted therapies in oncology: in the crosshairs or at the crossroads?
Higa GM
Expert Rev Anticancer Ther; 2004 Feb; 4(1):61-75. PubMed ID: 14748658
[TBL] [Abstract][Full Text] [Related]
4. Targeting angiogenesis in lung cancer.
Sandler AB
Semin Oncol; 2005 Dec; 32(6 Suppl 10):S16-22. PubMed ID: 16459175
[TBL] [Abstract][Full Text] [Related]
5. Key cancer cell signal transduction pathways as therapeutic targets.
Bianco R; Melisi D; Ciardiello F; Tortora G
Eur J Cancer; 2006 Feb; 42(3):290-4. PubMed ID: 16376541
[TBL] [Abstract][Full Text] [Related]
6. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
Faivre S; Djelloul S; Raymond E
Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
[TBL] [Abstract][Full Text] [Related]
7. [Molecular therapy targets in lung cancer].
Le Guen Y; Sabatier L; Le Chevalier T; Soria JC
Bull Cancer; 2003 Dec; 90(12):1055-61. PubMed ID: 14715425
[TBL] [Abstract][Full Text] [Related]
8. Molecularly targeted therapy for malignant glioma.
Sathornsumetee S; Reardon DA; Desjardins A; Quinn JA; Vredenburgh JJ; Rich JN
Cancer; 2007 Jul; 110(1):13-24. PubMed ID: 17520692
[TBL] [Abstract][Full Text] [Related]
9. Molecular oncology--perspectives in lung cancer.
Huber RM; Stratakis DF
Lung Cancer; 2004 Aug; 45 Suppl 2():S209-13. PubMed ID: 15552801
[TBL] [Abstract][Full Text] [Related]
10. Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway.
Gollob JA; Wilhelm S; Carter C; Kelley SL
Semin Oncol; 2006 Aug; 33(4):392-406. PubMed ID: 16890795
[TBL] [Abstract][Full Text] [Related]
11. Targeting mTOR signaling in lung cancer.
Marinov M; Fischer B; Arcaro A
Crit Rev Oncol Hematol; 2007 Aug; 63(2):172-82. PubMed ID: 17540577
[TBL] [Abstract][Full Text] [Related]
12. Thioredoxin reductase as a novel molecular target for cancer therapy.
Nguyen P; Awwad RT; Smart DD; Spitz DR; Gius D
Cancer Lett; 2006 May; 236(2):164-74. PubMed ID: 15955621
[TBL] [Abstract][Full Text] [Related]
13. Advances in preclinical small molecules for the treatment of NSCLC.
Zhang Q; Feng W; Zhou H; Yan B
Expert Opin Ther Pat; 2009 Jun; 19(6):731-51. PubMed ID: 19456275
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetics and mechanisms of apoptosis in carcinomas of the lung and pleura: therapeutic targets.
Motadi LR; Misso NL; Dlamini Z; Bhoola KD
Int Immunopharmacol; 2007 Dec; 7(14):1934-47. PubMed ID: 18039530
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomics in non-small-cell lung cancer chemotherapy.
Danesi R; Pasqualetti G; Giovannetti E; Crea F; Altavilla G; Del Tacca M; Rosell R
Adv Drug Deliv Rev; 2009 May; 61(5):408-17. PubMed ID: 19292993
[TBL] [Abstract][Full Text] [Related]
16. Intracellular signal transduction pathway proteins as targets for cancer therapy.
Adjei AA; Hidalgo M
J Clin Oncol; 2005 Aug; 23(23):5386-403. PubMed ID: 15983388
[TBL] [Abstract][Full Text] [Related]
17. Multitargeted inhibitors in lung cancer: new clinical data.
Bar J; Herbst RS; Onn A
Clin Lung Cancer; 2008; 9 Suppl 3():S92-9. PubMed ID: 19419930
[TBL] [Abstract][Full Text] [Related]
18. The biological framework: translational research from bench to clinic.
Yarden Y
Oncologist; 2010; 15 Suppl 5():1-7. PubMed ID: 21138950
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation: its role in lung carcinogenesis and therapeutic implications.
Santos ES; Raez LE; DeCesare T; Singal R
Expert Rev Anticancer Ther; 2005 Aug; 5(4):667-79. PubMed ID: 16111467
[TBL] [Abstract][Full Text] [Related]
20. [A novel paradigm and new targets in cancer therapy].
Novik AA; Kamilova TA; Tsygan VN
Vopr Onkol; 2003; 49(6):695-704. PubMed ID: 14976912
[No Abstract] [Full Text] [Related]
[Next] [New Search]
